Home/Filings/4/0000899243-22-024391
4//SEC Filing

Heinen Mark 4

Accession 0000899243-22-024391

CIK 0001832415other

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 4:24 PM ET

Size

5.9 KB

Accession

0000899243-22-024391

Insider Transaction Report

Form 4
Period: 2022-06-24
Heinen Mark
See Remarks
Transactions
  • Purchase

    Common Stock

    2022-06-24$1.75/sh+2,280.605$4,0002,280.605 total(indirect: By daughter)
Holdings
  • Common Stock

    20,000
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.7539 to $1.7576, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Issuer

Better Therapeutics, Inc.

CIK 0001832415

Entity typeother

Related Parties

1
  • filerCIK 0001888531

Filing Metadata

Form type
4
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 4:24 PM ET
Size
5.9 KB